Connection

Co-Authors

This is a "connection" page, showing publications co-authored by John Moore and Rogier Sanders.
Connection Strength

3.967
  1. Virus vaccines: proteins prefer prolines. Cell Host Microbe. 2021 03 10; 29(3):327-333.
    View in: PubMed
    Score: 0.934
  2. Native-like Env trimers as a platform for HIV-1 vaccine design. Immunol Rev. 2017 01; 275(1):161-182.
    View in: PubMed
    Score: 0.698
  3. HIV's Achilles' Heel. Sci Am. 2016 11 15; 315(6):50-55.
    View in: PubMed
    Score: 0.692
  4. Antibody Responses to SARS-CoV-2 mRNA Vaccines Are Detectable in Saliva. Pathog Immun. 2021; 6(1):116-134.
    View in: PubMed
    Score: 0.237
  5. Immunogenicity in Rabbits of HIV-1 SOSIP Trimers from Clades A, B, and C, Given Individually, Sequentially, or in Combination. J Virol. 2018 04 15; 92(8).
    View in: PubMed
    Score: 0.190
  6. Epitopes for neutralizing antibodies induced by HIV-1 envelope glycoprotein BG505 SOSIP trimers in rabbits and macaques. PLoS Pathog. 2018 02; 14(2):e1006913.
    View in: PubMed
    Score: 0.189
  7. Stabilization of the gp120 V3 loop through hydrophobic interactions reduces the immunodominant V3-directed non-neutralizing response to HIV-1 envelope trimers. J Biol Chem. 2018 02 02; 293(5):1688-1701.
    View in: PubMed
    Score: 0.186
  8. Design and crystal structure of a native-like HIV-1 envelope trimer that engages multiple broadly neutralizing antibody precursors in vivo. J Exp Med. 2017 Sep 04; 214(9):2573-2590.
    View in: PubMed
    Score: 0.183
  9. Reducing V3 Antigenicity and Immunogenicity on Soluble, Native-Like HIV-1 Env SOSIP Trimers. J Virol. 2017 08 01; 91(15).
    View in: PubMed
    Score: 0.181
  10. Improving the Expression and Purification of Soluble, Recombinant Native-Like HIV-1 Envelope Glycoprotein Trimers by Targeted Sequence Changes. J Virol. 2017 06 15; 91(12).
    View in: PubMed
    Score: 0.179
  11. Two HIV-1 variants resistant to small molecule CCR5 inhibitors differ in how they use CCR5 for entry. PLoS Pathog. 2009 Aug; 5(8):e1000548.
    View in: PubMed
    Score: 0.105
  12. Developability Assessment of Physicochemical Properties and Stability Profiles of HIV-1 BG505 SOSIP.664 and BG505 SOSIP.v4.1-GT1.1 gp140 Envelope Glycoprotein Trimers as Candidate Vaccine Antigens. J Pharm Sci. 2019 07; 108(7):2264-2277.
    View in: PubMed
    Score: 0.051
  13. Structural and immunologic correlates of chemically stabilized HIV-1 envelope glycoproteins. PLoS Pathog. 2018 05; 14(5):e1006986.
    View in: PubMed
    Score: 0.048
  14. Integrity of Glycosylation Processing of a Glycan-Depleted Trimeric HIV-1 Immunogen Targeting Key B-Cell Lineages. J Proteome Res. 2018 03 02; 17(3):987-999.
    View in: PubMed
    Score: 0.047
  15. High-Throughput Protein Engineering Improves the Antigenicity and Stability of Soluble HIV-1 Envelope Glycoprotein SOSIP Trimers. J Virol. 2017 11 15; 91(22).
    View in: PubMed
    Score: 0.046
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.